Morning Stock Movers: Alibaba, Eli Lilly, Clorox, Take-Two

The video discusses earnings reports from several companies, including Alibaba, Eli Lilly, Clorox, Take-Two, and Lyft. Alibaba's earnings show resilience despite regulatory challenges, while Eli Lilly faces a decline in COVID therapy sales but focuses on Alzheimer's treatment. Clorox experiences a significant drop in sales post-pandemic, and Take-Two misses estimates, affecting its stock. Lyft, despite being a money-losing company, shows growth in active riders and revenue per rider. The video also highlights the impact of regulatory issues in China on the tech and video game sectors.

What was the quarterly revenue reported by Alibaba?

How did Eli Lilly's earnings report affect its stock price?

What challenges is Clorox facing according to the earnings report?

What was the impact of Take-Two's earnings report on its stock?

What are Lyft's expectations regarding active riders and profitability?